Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II-III Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06221748
What this trial is testing

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT03092518
What this trial is testing

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

Who this might be right for
Gastric AdenocarcinomaEsophagogastric JunctionGastric Cancer
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)UnknownNCT01583361
What this trial is testing

SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Lin Chen 772
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Large-scale testing (Phase 3)UnknownNCT02628665
What this trial is testing

Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer

Who this might be right for
Stage I Esophageal AdenocarcinomaStage II Esophageal AdenocarcinomaStage III Esophageal Adenocarcinoma+3 more
The First Affiliated Hospital of Henan University of Science and Technology 40
Not applicableStudy completedNCT05465993
What this trial is testing

The Optimal Surveillance Frequency for Stage II/III Gastric Cancer

Who this might be right for
Gastric Cancer
Fujian Medical University 2,311
Large-scale testing (Phase 3)Study completedNCT00639327
What this trial is testing

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Japan Clinical Cancer Research Organization 300
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT04483076
What this trial is testing

Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer

Who this might be right for
Gastric CancerChemotherapy Effect
Chinese PLA General Hospital 524
Large-scale testing (Phase 3)Ended earlyNCT05149807
What this trial is testing

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

Who this might be right for
Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 81
Not applicableUnknownNCT01905969
What this trial is testing

Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy

Who this might be right for
Gastric Cancer
Iwate Medical University 500
Testing effectiveness (Phase 2)UnknownNCT02572050
What this trial is testing

Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal Dissection

Who this might be right for
Gastric Cancer
National Cancer Center, Korea 87
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Testing effectiveness (Phase 2)Study completedNCT00045526
What this trial is testing

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03257163
What this trial is testing

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

Who this might be right for
Epstein-Barr Virus PositiveGastric AdenocarcinomaMismatch Repair Protein Deficiency+8 more
Rutgers, The State University of New Jersey 40
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT04523818
What this trial is testing

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Who this might be right for
Clinical Stage I Gastric Cancer AJCC v8Clinical Stage IIA Gastric Cancer AJCC v8Clinical Stage III Gastric Cancer AJCC v8+13 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Next Page